Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $127,791,557    

Indirect Value

   $39,090,220      
Total Shares   87,362,343      
Total Value   $166,881,777      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,890,936 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $3,898,668 Achieve Life Sciences Inc $3,889,807 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $103,278 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,902,669 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,890,936 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $3,898,668 Achieve Life Sciences Inc $3,889,807 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $103,278 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,902,669 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-06-27 4 S $0.52 $486,888 I/I (937,404) 731,458 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-06-26 4 S $0.61 $1,682,010 I/I (2,746,138) 1,668,862 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-02-07 4 B $0.00 $0 I/I 450,000 4,415,000 1.42 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-02-03 4 A $3.95 $1,319 I/I 334 3,965,000 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-03-14 4 B $0.65 $64,940 I/I 100,000 47,576,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-03-11 4 B $0.69 $68,780 I/I 100,000 47,476,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-03-10 4 B $0.70 $18,226 I/I 26,000 47,376,000 2.17 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-03-07 4 B $0.66 $213,330 I/I 325,000 47,350,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-03-04 4 B $0.70 $95,108 I/I 135,000 47,025,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-03-03 4 B $0.71 $35,695 I/I 50,000 46,890,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-25 4 B $0.79 $31,716 I/I 40,000 46,840,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-24 4 B $0.80 $80,090 I/I 100,000 46,800,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-22 4 B $0.77 $64,076 I/I 83,000 46,700,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-18 4 B $0.82 $45,238 I/I 55,000 46,617,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-17 4 B $0.82 $122,250 I/I 150,000 46,562,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-20 4 B $0.85 $10,208 I/I 12,000 46,412,000 2.17 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-19 4 B $0.88 $82,053 I/I 93,700 46,400,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-18 4 B $0.88 $182,225 I/I 206,300 46,306,300 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-14 4 B $0.93 $78,974 I/I 85,000 46,100,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-13 4 B $1.00 $314,013 I/I 312,700 46,015,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-12 4 B $1.04 $59,781 I/I 57,300 45,702,300 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-11 4 B $0.96 $15,342 I/I 16,003 45,645,000 2.17 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-10 4 B $0.99 $484,615 I/I 491,097 45,628,997 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-07 4 B $1.04 $142,975 I/I 137,900 45,137,900 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-09-17 4 B $2.20 $11,999,999 I/I 5,454,545 45,000,000 2.25 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us